Denali Therapeutics Inc. Accounts Payable for the year ending December 31, 2024: USD 11.14 M

Denali Therapeutics Inc. Accounts Payable is USD 11.14 M for the year ending December 31, 2024, a 17.44% change year over year. Accounts payable are amounts owed by the company to suppliers or vendors for goods or services received but not yet paid.
  • Denali Therapeutics Inc. Accounts Payable for the year ending December 31, 2023 was USD 9.48 M, a 239.89% change year over year.
  • Denali Therapeutics Inc. Accounts Payable for the year ending December 31, 2022 was USD 2.79 M, a -41.62% change year over year.
  • Denali Therapeutics Inc. Accounts Payable for the year ending December 31, 2021 was USD 4.78 M, a 346.22% change year over year.
  • Denali Therapeutics Inc. Accounts Payable for the year ending December 31, 2020 was USD 1.07 M, a -58.65% change year over year.
Key Data
Date Accounts Payable Short-Term Debt Long-Term Debt Total Liabilities